IL6 and hepatocellular carcinoma: It is well-known that pro-inflammatory cytokines that induced chronic inflammatory response have to be considered as two potent activators of pro-oncogenic signaling that were linked to HCC onset136, such as IL-6 prevents DNA-damage-induced hepatocyte apoptosis through suppression of p53 and enhances β-catenin activation137.